Printable version (PDF) 

TAXATION

– R&D acquisitions, accounting rules sought, 616
– R&D credit

– – Guidance on R&D credit, IRS supplements, 85
– – Permanent R&D credit

See LEGISLATION, FEDERAL, HR 1545

– – Small business support permanent R&D credit, 490

TERRORISM

– Chemist seeks access to select agents (D.D.C.), 659
– Dual-use threats, concerned scientists may have overreacted by excluding foreigners from labs, report says, 116
– HHS countermeasures funding, GAO reports, 522
– High-containment biolabs, GAO reports on oversight, 658
– Misuse of select agents, NRC/NIH report on preventing, 669
– Security at biolabs may hinder international collaboration, 196
– Synthetic biology, Analysis & Perspective, 571

TEXAS

– Birth defect surveillance, In Brief, 593
– Stem cell grant rules, In Brief, 621

TRADEMARKS

– Mouse strain for human cell engraftment, infringement alleged (N.D. Cal.), 77

TROVAN

– Nigerian clinical trial claims

– – Hearing planned on claim that Pfizer tried to circumvent victims' attorneys (Conn. Super. Ct.), 362
– – Jurisdiction, claims may be tried in U.S. (2nd Cir.), 73; (U.S., rev sought), 516
– – Kano settles with Pfizer, 513
– – Settlement reported, 117; settlement said near, 276

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.